<DOC>
	<DOCNO>NCT01050387</DOCNO>
	<brief_summary>The purpose study determine vitamin D binding protein genotype influence circulate vitamin D level may functional consequence vitamin D activity .</brief_summary>
	<brief_title>Effects Vitamin D Dose Genotype Binding Protein Infants Children</brief_title>
	<detailed_description>Vitamin D recently subject much attention . Advantages prevention vitamin D deficiency ( VDD ) young child obvious : acutely , hypocalcemic seizure may occur VDD , rickets result long-term skeletal deformity . Previous research emphasize importance identify optimal supplementation dos appropriate target threshold circulate 25-hydroxyvitamin D ( 25-OHD ) , best describe marker vitamin D status . The timely next step objectively establish effective dos prevention VDD , without create risk overzealous supplementation , population representative risk overt disease . Although primary role vitamin D consider effect intestinal calcium absorption , enormous variability fractional calcium absorption relation 25-OHD level exists . We provide evidence significant component variability genetic nature particular , relate vitamin D binding protein ( DBP ) genotype . The aggregate data suggest critical mechanism development nutritional rickets reduction availability calcium skeleton , largely determine vitamin D status intestinal calcium absorption . Our proposal focus establishment workable definition vitamin D deficiency underserved highly vulnerable population assess impact genetic variance VDR DBP factor consider recommendation vitamin D status assessment , take account outcome 25-OHD level , additional study , potential functional consequence vitamin D related classical non-classical effect .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>6 month 6 year age healthy free disease condition may affect nutritional status bone metabolism willingness family participate 6month study vitamin D supplementation Chronic disease Prematurity &lt; 32 week gestational age Liver disease hepatitis renal/urologic disease ( e.g. , recurrent urinary tract infection ) Use pharmacologic prescriptionlevel dosage vitamin D metabolite . We exclude user systemic glucocorticoid preparation user inhale steroid consider great medium dose age 4 yr . Specifically , would exclude user 1 mg/day budesonide , 352 mcg/day fluticasone . Current recent ( within 1 month ) use anticonvulsant medication know affect bone mineral homeostasis alkaline phosphatase level .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Vitamin D Deficiency</keyword>
	<keyword>VDD</keyword>
	<keyword>Vitamin D Supplementation</keyword>
	<keyword>Vitamin D Binding Protein</keyword>
	<keyword>DBP</keyword>
	<keyword>Nutritional rickets</keyword>
	<keyword>rickets</keyword>
	<keyword>25hydroxyvitamin D</keyword>
	<keyword>25OHD</keyword>
	<keyword>1,25OH2D</keyword>
	<keyword>vitamin D metabolite</keyword>
	<keyword>PTH</keyword>
	<keyword>vitamin D homeostasis</keyword>
</DOC>